Reducing Alcohol and Smoking Dependency through Artificial Intelligence: A Critical Analysis
Keywords:
Alcohol Dependency; Smoking Dependency; Artificial Intelligence; RespondentAbstract
This study report critically analyses the efficacy of using Artificial Intelligence (AI) to reduce alcohol and smoking addictions. The main goal is to evaluate the effectiveness of AI technology in delivering individualized and focused assistance for addiction cessation. The study used a combined-technique approach, using both qualitative and quantitative data gathering techniques. A structured survey was conducted with 100 participants to collect demographic data, evaluate the extent of alcohol and smoking addiction, and explore the participants' perspectives on AI-driven therapies. Qualitative data was collected via detailed interviews and focus group discussions to provide a nuanced insight into individual experiences and perspectives. The research employs sophisticated AI algorithms to examine the gathered data, detecting patterns and relationships among demographic characteristics, dependence levels, and reactions to AI interventions. The results emphasize the need of customized treatments, using artificial intelligence to adjust treatment strategies according to individual requirements and preferences. It is determined that 95.0% of individuals agree or strongly agree on the significance of AI integration. The Cronbach's Alpha value of 0.871 indicates that the survey questions effectively assess the desired constructs of addiction treatment effectiveness in a reliable manner.
Downloads
References
M. R. Lee, V. Sankar, A. Hammer, W. G. Kennedy, J. J. Barb, P. G. McQueen, et al., "Using machine learning to classify individuals with alcohol use disorder based on treatment seeking status," EClinical Medicine, vol. 12, pp. 70–78, 2019.
D. Liu, Y. C. Li, W. Zhang, and L. Zhang, "A brief review of artificial intelligence applications and algorithms for psychiatric disorders," Engineering, vol. 6, no. 4, pp. 462–467, 2020.
S. Mackey, N. Allgaier, B. Chaarani, P. Spechler, C. Orr, and J. Bunn, "Mega-analysis of gray matter volume in substance dependence: General and substance-specific regional effects," American Journal of Psychiatry, vol. 176, no. 2, pp. 119–128, 2019.
R. McKetin, J. Leung, E. Stockings, Y. Huo, J. Foulds, J. M. Lappin, et al., "Mental health outcomes associated with the use of amphetamines: A systematic review and meta-analysis," EClinical Medicine, vol. 16, pp. 81–97, 2019.
R. A. Rabin, S. Mackey, M. A. Parvaz, et al., "Common and gender-specific associations with cocaine use on gray matter volume: Data from the ENIGMA addiction working group," Human Brain Mapping, pp. 1–12, 2020.
S. Lalic, J. Ilomäki, J. S. Bell, M. J. Korhonen, and N. Gisev, "Prevalence and incidence of prescription opioid analgesic use in Australia," British Journal of Clinical Pharmacology, vol. 85, no. 1, pp. 202–215, 2019.
S. Kinreich, V. V. McCutcheon, F. Aliev, J. L. Meyers, C. Kamarajan, A. K. Pandey, et al., "Predicting alcohol use disorder remission: A longitudinal multimodal multi-featured machine learning approach," Translational Psychiatry, vol. 11, no. 1, p. 166, Mar. 15, 2021.
Rehman, S. Naz, and I. Razzak, "Leveraging big data analytics in healthcare enhancement: Trends, challenges and opportunities," Multimedia Systems, vol. 28, no. 4, pp. 1339–1371, 2022.
M. Guggenmos, K. Schmack, I. M. Veer, T. Lett, M. Sekutowicz, M. Sebold, et al., "A multimodal neuroimaging classifier for alcohol dependence," Scientific Reports, vol. 10, no. 1, pp. 1–12, 2020.
Marcon, F. de Ávila Pereira, A. Zimerman, B. C. da Silva, L. von Diemen, I. C. Passos, et al., "Patterns of high-risk drinking among medical students: A web-based survey with machine learning," Computers in Biology and Medicine, vol. 136, article 104747, 2021.
Singhal, J. Mathew, and R. K. Behera, "Detection of alcoholism using EEG signals and a CNN-LSTM-ATTN network," Computers in Biology and Medicine, vol. 138, article 104940, 2021.
J. Van Amsterdam, E. Pennings, and W. van den Brink, "Fatal and non-fatal health incidents related to recreational ecstasy use," Journal of Psychopharmacology (Oxford, England), vol. 34, no. 6, pp. 591–599, 2020.
L. Zoboroski, T. Wagner, and B. Langhals, "Classical and neural network machine learning to determine the risk of marijuana use," International Journal of Environmental Research and Public Health, vol. 18, no. 14, article 7466, Jul 13, 2021. PMID: 34299915; PMCID: PMC8304402.
S. Verma, L. Warrier, B. Bolia, and S. Mehta, "Past, present, and future of virtual tourism-a literature review," International Journal of Information Management Data Insights, vol. 2, no. 2, article 100085, 2022.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Lakshya Tanwar
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJISAE open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
